Results 271 to 280 of about 302,518 (309)
Some of the next articles are maybe not open access.
2021
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +1 more source
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +1 more source
Treatment of Chronic Hepatitis B
Current Pharmaceutical Design, 2002Infection with the hepatitis B virus has switched over the last 20 years from the classical HBeAg positive serologic pattern to a HBeAg negative form that is linked, in the Mediterranean basin, with the epidemiologic replacement of the causative wild-type of virus B with mutant variants, whereby mutations in the core-promoter and in the pre-core region
M, Lagget, M, Rizzetto
openaire +2 more sources
Treatment of chronic hepatitis B
The Lancet Infectious Diseases, 2001This review updates the treatment of chronic hepatitis B infection. Complete eradication of hepatitis B virus (HBV) is not possible, so the efficacy of treatment has to be assessed by whether it can limit long-term cirrhosis-related complications. We discuss two major groups of treatments--immunomodulators (interferon alfa, thymosin alpha1, therapeutic
Lai, CL, Yuen, MF
openaire +4 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +2 more sources
JAMA, 2018
More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer.Pegylated interferon and nucleos(t)ide analogues (lamivudine, adefovir, entecavir, tenofovir disoproxil, and ...
Lydia S Y, Tang +3 more
openaire +2 more sources
More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer.Pegylated interferon and nucleos(t)ide analogues (lamivudine, adefovir, entecavir, tenofovir disoproxil, and ...
Lydia S Y, Tang +3 more
openaire +2 more sources
Treatment of chronic hepatitis B
Journal of Viral Hepatitis, 1994SUMMARY.Chronic infection with the hepatitis B virus (HBV) is a major cause of worldwide morbidity and mortality. A large number of therapeutic approaches has been tried, including interferon (IFN), nucleoside analogues and immunomodulators. To date controlled clinical trials have shown that only IFN is of long‐term value but many patients fail to ...
openaire +2 more sources
Management of Chronic Hepatitis B
2011Chronic hepatitis B affects 400 million people worldwide. The criteria for initiating and stopping treatment are still under debate in spite of well-established agents for its treatment.
Lai, CL, Yuen, MF
openaire +2 more sources
Treatment of Chronic Hepatitis B
Minerva gastroenterologica e dietologica, 2010Approximately 350-420 million people worldwide are chronically infected with hepatitis B virus (HBV). Chronic hepatitis B can result in liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Reactivation of hepatitis B is possible in patients with inactive or resolved hepatitis B often leading to liver failure.
Lai, CL, Yuen, RMF
openaire +4 more sources
Hepatitis B e‐antigen negative chronic hepatitis B
Journal of Gastroenterology and Hepatology, 2002S K, Sarin, S K, Satapathy, R, Chauhan
openaire +2 more sources